[1]
BuliƄska, N. et al. 2026. GLP-1 RECEPTOR AGONISTS VERSUS METFORMIN IN POLYCYSTIC OVARY SYNDROME: METABOLIC BENEFITS, REPRODUCTIVE OUTCOMES AND THE EVIDENCE GAP IN LEAN PCOS. International Journal of Innovative Technologies in Social Science. 5, 2(50) (Jun. 2026). DOI:https://doi.org/10.31435/ijitss.2(50).2026.5563.